Fundraising FoxInterAct Therapeutics
Dallas, US · Founded 2025 · Delaware corporation
Find your way into InterAct Therapeutics
Sign up to see every warm intro you have to InterAct Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the InterAct Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DH
Daniel HargroveMr. Hargrove is the CEO and a director of the Issuer.He has experience in biotech investing, commercialization, FDA regulatory compliance, government contracting, and military law.
Board
IC
Isaac ChanDr. Chan is a director of the Issuer
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2026
▶$250KraisedJul 2026 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJul 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HargroveExecutive Officer, Director
- Isaac ChanDirector
- Offering amount
- $2M
- Amount sold
- $250K
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has InterAct Therapeutics raised?
- InterAct Therapeutics has disclosed $250K raised across 1 round.
- Where is InterAct Therapeutics headquartered?
- InterAct Therapeutics is headquartered in Dallas, US.